{"entity":{"id":"nct06593431","kind":"trial","name":"Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial","aka":["EXPAND"],"tldr":"A phase 3 trial in pancreatic cancer, run by M.D. Anderson Cancer Center, now recruiting.","summary":"Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial is a phase 3, randomised interventional study registered as NCT06593431 by M.D. Anderson Cancer Center, with a registry enrolment figure of 80 participants, started 2024-10-23 and due to reach its primary completion in 2029-06-29. Interventions recorded: Consolidative Radiation. Conditions listed: Pancreas Cancer; Oligometastatic. Primary outcome: Safety and Adverse Events (AEs). Pancreatic eligibility wording from the registry: \"Histologically or cytologically confirmed pancreatic ductal adenocarcinoma\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06593431","url":"https://clinicaltrials.gov/study/NCT06593431"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["metastatic-pdac"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06593431","phase":"3","setting":"Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial","sponsor":"M.D. Anderson Cancer Center","participation":[{"nct":"NCT06593431","source":"https://clinicaltrials.gov/study/NCT06593431","fetchedAt":"2026-10-07T16:54:49.791Z","studySha256":"77b341a4ba594c2a01c92919f2c892a80c0658ba36edb9ab7c3b4d623c4893f2","overallStatus":"RECRUITING","lastUpdatePosted":"2026-10-06","leadSponsor":"M.D. Anderson Cancer Center","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":80,"enrolmentType":"ESTIMATED","siteCount":4,"recruitingSiteCount":4,"countries":["United States"]}],"started":"2024-10-23","startedType":"actual","enrolled":80,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06593431/","neighbours":{"cancer":[{"id":"metastatic-pdac","kind":"cancer","name":"Metastatic pancreatic ductal adenocarcinoma","route":"/cancers/metastatic-pdac/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}